Table 1.

Median observed VRC01 bnAb concentrations among recipients without HIV-1 by dosing regimen and by trial.

AMP trial	Median VRC01 serum concentration
	10 mg/kg	30 mg/kg	VRC01 pooled
HVTN 704/HPTN 085	9.3 mg/ml (n = 19)	28.4 mg/ml (n = 21)	18.7 mg/ml
HVTN 703/HPTN 081	12.2 mg/ml (n = 21)	32.1 mg/ml (n = 21)	20.5 mg/ml
Pooled	10.1 mg/ml	31.0 mg/ml	19.6 mg/ml

The values are calculated from the subset of case-control data set for VRC01 recipients without HIV-1, as medians of participant-specific medians over all mid-infusion visits through to the week 76 visit (n=82).

The number of recipients without HIV-1 included in subsequent analyses is listed in parentheses for each group.